Related Experiment Video
Updated: Jan 29, 2026

Isolation of Conditionally Immortalized Mouse Glomerular Endothelial Cells with Fluorescent Mitochondria
Published on: September 13, 2022
Long noncoding RNA MALAT1 mediates high glucose-induced glomerular endothelial cell injury by epigenetically
Yebei Li1, Daijin Ren1, Gaosi Xu1
1Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract:
Several recent reporters have indicated the potential role of long noncoding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) in diabetic nephropathy (DN). However, these studies mainly focus on renal tubular epithelial cells HK-2, the role of MALAT1 in human renal glomerular endothelial cells (HRGECs) remains unclear. Hence, this study aimed to explore the role of MALAT1 in high glucose (HG)-induced HRGECs injury and the underlying epigenetic mechanism. Increased MALAT1 and decreased klotho expression were observed in both renal tissues from DN patients and HG-exposed HRGECs. Furthermore, MALAT1 expression was negatively correlated with klotho expression. Moreover, both MALAT1 knockdown and klotho overexpression significantly abolished the HG-induced HRGECs injury. Importantly, klotho overexpression reversed the MALAT1 overexpression-mediated enhancement of the HG-induced HRGECs injury. In addition, MALAT1 recruited G9a to elevate H3K9me1, which can bind to the klotho promoter and thus inhibited klotho transcription. In conclusion, MALAT recruits methyltransferase G9a to elevate H3K9me1 and epigenetically inhibits klotho expression, and thus mediates HG-induced glomerular endothelial cell injury. © 2019 IUBMB Life, 1-9, 2019.
Insights
Long noncoding RNA MALAT1 exacerbates diabetic nephropathy by epigenetically silencing klotho in kidney cells. Reducing MALAT1 or boosting klotho protects against high glucose-induced injury.
Area of Science:
- Molecular Biology
- Epigenetics
- Renal Physiology
Background:
- Diabetic nephropathy (DN) is a major complication of diabetes.
- Long noncoding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) is implicated in DN.
- The role of MALAT1 in human renal glomerular endothelial cells (HRGECs) is not well understood.
Purpose of the Study:
- To investigate the role of MALAT1 in high glucose (HG)-induced HRGECs injury.
- To elucidate the epigenetic mechanism underlying MALAT1's function in DN.
- To explore the relationship between MALAT1 and klotho expression in HRGECs.
Main Methods:
- Analysis of MALAT1 and klotho expression in DN patient renal tissues and HG-exposed HRGECs.
- MALAT1 knockdown and klotho overexpression experiments in HRGECs.
- Investigation of the interaction between MALAT1, G9a, H3K9me1, and the klotho promoter.
Main Results:
- Increased MALAT1 and decreased klotho expression were observed in DN tissues and HG-exposed HRGECs.
- MALAT1 expression negatively correlated with klotho expression.
- MALAT1 knockdown and klotho overexpression protected HRGECs from HG-induced injury.
- MALAT1 recruited G9a to increase H3K9me1, inhibiting klotho transcription.
Conclusions:
- MALAT1 epigenetically inhibits klotho expression by recruiting G9a and increasing H3K9me1.
- This mechanism mediates high glucose-induced glomerular endothelial cell injury in diabetic nephropathy.
- MALAT1 serves as a potential therapeutic target for DN.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
RNA Polymerase II Accessory Proteins
Feedback Inhibition
Glomerular Filtration
Components of the Filtration Membrane
The filtration process involves three key layers: the glomerular endothelial cells, the basement membrane, and the podocyte-formed filtration slits.
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

